A new test can accurately diagnose the Ebola virus disease within minutes at the point of care.
A small pilot study by Harvard-affiliated researchers finds symptom improvement and changes in expression of inflammation-associated genes in irritable bowel syndrome and inflammatory bowel disease patients who practice the relaxation response.
With Nepal struggling to grasp the enormous calamity caused by the magnitude 7.8 earthquake that struck north of Kathmandu Saturday, Harvard is mobilizing to help with technical and medical assistance and reaching out to faculty, staff, and students visiting the region.
Harvard researchers working at the Broad Institute of MIT and Harvard have uncovered nine rare genetic mutations that dramatically increase the risk of developing type 2 diabetes. The discovery of the mutations highlights the dizzying genetic diversity of a disease rapidly spreading around the world.
The protective gear needed to get Sierra Leone’s health clinics reopened, coupled with public education about the Ebola epidemic, are the greatest areas of need, according to a Harvard Fulbright Fellow and physician from Sierra Leone.
Syrian refugees struggling in Lebanon are on the edge of catastrophe, according to a new report from the FXB Center for Health and Human Rights.
Founding donor Hansjörg Wyss doubled his gift to Harvard’s Wyss Institute for Biologically Inspired Engineering from $125 million to $250 million to the University to further advance the institute’s pioneering work.
Members of the Harvard community responded to the Boston Marathon attacks and offered thoughts about both the physical and mental injuries they caused.
Researchers recently completed the first clinical study of a new rapid neuroassessment device they developed to quantitatively measure neuromuscular performance. The team is currently conducting a study with athletes in the Boston area to determine the sensitivity of the technology in diagnosing concussions.
A novel experiment illuminates the importance of the doctor-patient relationship, providing the first data into the underlying neurobiology of the caregiver.
In recent years Harvard investigators have discovered that breast tumors are influenced by more than just the cancer cells within them.
Researchers at Harvard Medical School and Harvard-affiliated Beth Israel Deaconess Medical Center have found that a type of immune cell plays a role in guarding against obesity, diabetes, and metabolic disease.
The annual symposium of the Wyss Institute for Biologically Inspired Engineering, held at Harvard Medical School, prompted a spirited discussion on robotics and medicine, with nature as a model.
Graduating Harvard Medical School student Katherine Johnson hopes to bridge barriers between doctors and patients by using her skills in the community as she begins her residency.
Harvard researchers have shown that a compound called rutin, commonly found in fruits and vegetables and sold over the counter as a dietary supplement, inhibits the formation of blood clots in an animal model of thrombosis.
Findings by a team at Harvard-affiliated Beth Israel Deaconess Medical Center suggest a new strategy for diagnosing and treating Alzheimer’s disease.
The twin epidemics of obesity and its cousin, diabetes, have been the target of numerous studies at Harvard and its affiliated hospitals and institutions. Harvard researchers have produced a dizzying array of findings on the often related problems.
As a liberal arts college, Harvard trains its students broadly so they can adapt nimbly to a rapidly changing world. Increasingly, appreciating and participating in music are integral parts of student life.
Synaptic plasticity — the ability of the synaptic connections between the brain’s neurons to change and modify over time — has been shown to be a key to memory formation and the acquisition of new learning behaviors. Now research reveals that the neural circuits controlling hunger and eating behaviors are also controlled by plasticity.
A new study from Harvard-affiliated Beth Israel Deaconess Medical Center finds that a group of little-explored cells in the tumor microenvironment likely serves as an important gatekeeper against cancer progression and metastasis.
Harvard scientists have rebuilt genetically diseased circuitry in a section of the mouse hypothalamus, an area controlling obesity and energy balance, demonstrating that complex and intricately wired circuitry of the brain long considered incapable of cellular repair can be rewired with the right type of neuronal “replacement parts.”
A new study led by a scientific team at Beth Israel Deaconess Medical Center and Harvard Medical School has uncovered another key mechanism that cancer cells use as part of their survival strategy — and once again it seems that they are using an enzyme called PKM2 to their advantage.
In ES 227, "Medical Device Design," SEAS students are given the opportunity to solve practical problems in a hospital setting, trying out the tools, learning about their use in real-world situations, and, in some cases, even sitting in on surgical procedures.
The Society for Vascular Surgery elected Harvard Medical School professor Marc Schermerhorn as a distinguished fellow.
When the final mission of NASA’s 30-year Space Shuttle program is launched on Friday (July 8), an animal experiment to test a novel therapy to increase bone mass will be on board. Harvard Medical School Asssistant Professor Mary Bouxsein is among the lead researchers.
A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and is potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Harvard investigators at the Dana-Farber Cancer Institute.
Harvard Medical School researchers believe that identifying the properties of the herpes viruses found in Africa could open the door to developing a more potent vaccine against an infection now rampant in sub-Saharan Africa.
Robert M. Goldwyn graduated from Harvard Medical School and later returned there and became Senior Surgeon at the Peter Bent Brigham and Beth Israel Hospitals.
President Drew Faust is traveling this week to highlight Harvard’s engagement with Latin America. In Brazil, she is reconnecting with alumni, exchanging ideas with the leaders of local universities, and meeting with Brazilian students who have studied alongside Harvard students or with Harvard faculty in Brazil.
Cancer geneticist Pier Paolo Pandolfi at Harvard-affiliated Beth Israel Deaconess Medical Center is the recipient of the 2011 Pezcoller Foundation-AACR International Award for Cancer Research.
Harvard researchers have estimated the likely cost-effectiveness of post-discharge follow-up phone calls to smokers hospitalized with acute heart attacks. In a report in the Archives of Internal Medicine, the researchers suggest that phone calls to these discharged smokers encouraging them to quit would yield significant health and economic gains.
Patients who were knowingly given placebos for irritable bowel syndrome experienced significant symptom relief when compared with controls.
Harvard scientists at Dana-Farber Cancer Institute say they have for the first time partially reversed age-related degeneration in mice, resulting in new growth of the brain and testes, improved fertility, and the return of a lost cognitive function.
Researchers at Harvard Medical School and the Harvard School of Dental Medicine have found that by mimicking a rare genetic disorder in a dish they can rewind the internal clock of a mature cell and drive it back into an adult stem-cell stage.
A noninvasive electric stimulation technique administered to both sides of the brain can help stroke patients who have lost motor skills in their hands and arms, according to a new study led by researchers at Beth Israel Deaconess Medical Center.
Using a real-time imaging system, scientists have tracked a group of near-infrared fluorescent nanoparticles from the airspaces of the lungs into the body and out again, providing a description of the characteristics and behavior of the particles that could be used in developing therapeutic agents to treat pulmonary disease.
An interdisciplinary group of leading Harvard geneticists and stem cell researchers has found a new genetic aspect of cell reprogramming that may ultimately help in the fine-tuning of induced pluripotent stem cells (iPS) into specific cell types.
Instead of relying on doctors’ reports about adverse events, Harvard's Dr. Daniel Leffler used electronic medical records to track emergency visits and hospital admissions that occurred within two weeks of a colonoscopy or upper-gastrointestinal endoscopy and that appeared to be related to the procedures…
Unlike previous investigations, which examined fat cells at a single static time point, this new study mapped several histone modifications throughout the course of fat cell development. With these new findings researchers now have a better understanding of normal fat cell development, and going forward, they can compare normal fat cells with fat cells in disease states.
Researchers, led by Harvard Medical School Assistant Professor Shiladitya Sengupta, have devised a way to improve a low-cost, effective cancer drug, cisplatin, whose use has been limited by its toxicity.
The Internet has had a profound effect on clinical practice by providing both physicians and patients with a wealth of information. But with those rewards ...
Harvard will start gardens for growing food in April, with students taking a lead role.
Volunteers assist with a variety of medical skills, from nursing to orthopedics to medical equipment repair, playing a critical role in the response to the Haitian earthquake.
Harvard-affiliated doctors report on carnage, rescue operations in quake-ravaged Haiti, as medical teams gain traction.
Ask people who suffer from migraine headaches what they do when they’re having attacks, and you’re likely to hear “go into a dark room.” ...
Harvard faculty members from a range of fields give tips on how to live healthy.
John Rinn, a researcher at Harvard Medical School, the Beth Israel Deaconess Medical Center, and the Broad Institute, overcame a rocky start in life through a passion for biology and discovered a new category of RNAs.
Donald Baim, renowned cardiologist, medical device executive, and former Harvard Medical School professor, died on Nov. 6 at the age of 60.
Beth Israel Deaconess Medical Center geneticist John Rinn, whose research has helped uncover a new class of RNA, has been named to this year’s “Brilliant 10” list of top young scientists by Popular Science magazine.
In an editorial accompanying the journal paper, Dr. Raphael Dolin of the Beth Israel Deaconess Medical Center in Boston said the overall findings were nonetheless "of potentially great importance to the field of HIV research" because they might yield information about the kinds of immune responses necessary to provide protection against the virus….